scispace - formally typeset
Search or ask a question

Showing papers by "Joachim von Pawel published in 1997"

Journal Article•DOI•
Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

[...]

Christian Manegold, B. Bergman, Assad Chemaissani, W. Dornoff, Peter Drings, P. Kellokumpu-Lehtinen, K. Liippo1, Karin Mattson, Joachim von Pawel, S. Ricci, C. Sederholm, Rolf A. Stahel, Gunnar Wagenius, N. v. Walree, W. W. ten Bokkel-Huinink2 •
Turku University Hospital1, Netherlands Cancer Institute2
01 Jun 1997-Annals of Oncology
TL;DR: In this randomised study, single-agent gemcitabine was at least as active but better tolerated than the combination cisplatin-etoposide.

112 citations